Jul 10, 2019
Gout Therapeutic Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027
May 16, 2019
Data Analysis Published in Hypertension Shows Responders to Pegloticase Treatment Had Significant Decreases in Blood Pressure
Mar 08, 2019
Fears Nachawati Investigating Possible Uloric Lawsuits After FDA Issues Strongest Warning for Gout Drug
Jan 17, 2019
Acquist Announces Issuance of Two U.S. Patents Covering its Drug Library of Novel Small Molecules
Nov 14, 2018
Acquist Presents Positive Results for Its Lead NASH Drug, ACQT1127, at The Liver Meeting®
Oct 02, 2018
Acquist Therapeutics to Present Scientific Results for Lead Clinical Drug in Gout
Aug 22, 2018
Study Finds Salivary Uric Acid May Be an Important Biomarker for Indexing Health & Disease Risk
Jan 17, 2018
New Nationwide Survey on Gout Finds Patients with Gout and Chronic Kidney Disease are Sub-Optimally Treated
Nov 29, 2017
Nippon Chemiphar Announces Progress on Its Hyperuricemia/Gout Projects; NC-2500 Shows Favorable Profile to Lower Serum Uric Acid in Phase-1 Study
Nov 01, 2017
TWi Biotechnology Inc. Presents Positive Results from AC-201 CR Phase 2 Proof-of-Concept Study in Gout Patients in 2017 ACR/ARPH Annual Meeting
Oct 11, 2017
Relburn-Metabolomics to Present Developments in Lead Programs for NASH and Gout
Sep 27, 2017
Merck Manuals Answers: What is Gout?
Jun 20, 2017
Kibow Biotech Inc. (Buzz of Bio Winner, 2014) Receives US Patent for Gout/Hyperuricemia Product Formulation Based on Modulation of the Gut Microbiome With Probiotics and Prebiotics